Product category:
Contract research
News Release from: Argenta Discovery
Edited by the Laboratorytalk Editorial
Team on 08 January 2008
Electrophysiology and hERG screening
from Argenta
Argenta Discovery has entered into an alliance with NeuroSolutions to gain preferential access to its specialist electrophysiology and hERG testing services and expertise.
The collaboration will enable Argenta to provide its contract research clients with an expanded assay development and screening resource; either as part of an integrated drug discovery programme, or as a stand-alone service Christopher Ashton, chief executive officer of Argenta Discovery, said: "Argenta has been looking at ways of enhancing its biochemistry and in vitro screening capabilities
This article was originally published on Laboratorytalk on 24 Feb 2003 at 8.00am (UK)
Related stories
First spinal study of bone substitute
Study will measure performance of synthetic bone graft substitute in 30 patients undergoing spinal fusion for degenerative disc disease
Acquisition creates global CRO
Advanced Clinical Sciences becomes a global player in clinical research with the takeover of a Swiss CRO called CRC
"We have entered into this collaboration with NeuroSolutions to provide Argenta with dedicated access to specialist electrophysiology and hERG screening services, offered by a leader in the field.
"Argenta has a number of contract research programmes in the pipeline for 2008 which will benefit from NeuroSolutions's support and expertise.
"This alliance will enable Argenta to provide assay development and compound screening services across an even wider range of small molecule gene families.
"We are looking forward to working with NeuroSolutions".
Edward Stevens of NeuroSolutions added: "We are pleased to have entered into an alliance with Argenta Discovery.
"It has a well-earned reputation as a quality contract drug discovery service provider to the global pharmaceutical industry.
"NeuroSolutions is a recognised specialist in the electrophysiology and hERG screening fields, and our management team has over 30 years experience in the pharmaceutical and biotechnology sectors.
"This puts NeuroSolutions in a unique position to understand our clients' electrophysiological research needs, and fulfil their expectations".
"We are looking forward to assisting Argenta's contract research clients accelerate their drug discovery programmes.".
• Argenta Discovery: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
